Please login to the form below

Not currently logged in
Email:
Password:

PhRMA appoints new EVP of public affairs

The Pharmaceutical Research and Manufacturers of America has appointed Josephine Martin as executive vice president, public affairs
The Pharmaceutical Research and Manufacturers of America (PhRMA) has appointed Josephine Martin as executive vice president, public affairs, reporting to PhRMA president and CEO John J Castellani, with effect from March 1, 2011. 

Martin, former senior vice president of public affairs at Ketchum, will be responsible for leading and managing PhRMA's communications and alliance development functions. 

Before joining Ketchum, Martin held leading public affairs positions at Golin Harris and National Media, Inc. Her health policy communications experience was developed earlier in her career as senior vice president, public affairs for the Federation of American Hospitals, and vice president of communications at the American Red Cross.

"We are thrilled to have Josie join our team at PhRMA. She brings extensive and successful experience in DC public affairs – with a particular strength in health policy communications," Castellani said. 

Commenting on her appointment, Martin said: "There are few, if any, American industries that positively impact people's lives in so many ways -- from improving health and productivity to providing good jobs, to strengthening local and national economies – as the biopharmaceutical sector." 

"I am excited to join such an energised, impactful organisation as PhRMA, and I relish the chance to bring my experience to bear as we work to best convey the tremendous value of this innovative sector," she continued.

7th February 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...